Multi-target directed indole based hybrid molecules in cancer therapy: An up-to-date evidence-based review

Dhanya Sunil, Pooja R. Kamath

Research output: Contribution to journalReview article

14 Citations (Scopus)

Abstract

Cancer is a multifactorial disease and most of its types still remain incurable, in spite of enormous efforts to explicate various tumor pathophysiology. The anti-cancer drug discovery paradigm “one-compound-one-target” has failed and subsequently shifted to two-drug cocktail and recently the “multi-target approach” in order to design and develop agents able to act simultaneously on multiple intracellular constituents and signaling pathways. Novel hybrid compounds are now designed by incorporating two covalently linked independently acting pharmacores, each efficient at combating cancer. They can deliver synergistic effects from the dual action of both independently acting moieties by interacting with multiple targets. These composite molecules are also less prone to drug resistance, leading to an improved pharmacological potency than each individual moiety. As indole nucleus is a central component of many natural and synthetic molecules with extensive biological activity, this review incorporates a variety of such hybrid compounds with indole moiety as one of the active units, where better therapeutic effect has been successfully achieved, by either simultaneous or sequential action of individual functional pharmacore. The current limitations and challenges encountered in the development of these hybrid agents are also discussed.

Original languageEnglish
Pages (from-to)959-985
Number of pages27
JournalCurrent Topics in Medicinal Chemistry
Volume17
Issue number9
DOIs
Publication statusPublished - 01-04-2017

Fingerprint

Neoplasms
Therapeutic Uses
Drug Discovery
Therapeutics
Drug Resistance
Pharmacology
indole
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Drug Discovery

Cite this

@article{643fc0e2a51644eab7b3235073ac77c7,
title = "Multi-target directed indole based hybrid molecules in cancer therapy: An up-to-date evidence-based review",
abstract = "Cancer is a multifactorial disease and most of its types still remain incurable, in spite of enormous efforts to explicate various tumor pathophysiology. The anti-cancer drug discovery paradigm “one-compound-one-target” has failed and subsequently shifted to two-drug cocktail and recently the “multi-target approach” in order to design and develop agents able to act simultaneously on multiple intracellular constituents and signaling pathways. Novel hybrid compounds are now designed by incorporating two covalently linked independently acting pharmacores, each efficient at combating cancer. They can deliver synergistic effects from the dual action of both independently acting moieties by interacting with multiple targets. These composite molecules are also less prone to drug resistance, leading to an improved pharmacological potency than each individual moiety. As indole nucleus is a central component of many natural and synthetic molecules with extensive biological activity, this review incorporates a variety of such hybrid compounds with indole moiety as one of the active units, where better therapeutic effect has been successfully achieved, by either simultaneous or sequential action of individual functional pharmacore. The current limitations and challenges encountered in the development of these hybrid agents are also discussed.",
author = "Dhanya Sunil and Kamath, {Pooja R.}",
year = "2017",
month = "4",
day = "1",
doi = "10.2174/1568026616666160927150839",
language = "English",
volume = "17",
pages = "959--985",
journal = "Current Topics in Medicinal Chemistry",
issn = "1568-0266",
publisher = "Bentham Science Publishers B.V.",
number = "9",

}

Multi-target directed indole based hybrid molecules in cancer therapy : An up-to-date evidence-based review. / Sunil, Dhanya; Kamath, Pooja R.

In: Current Topics in Medicinal Chemistry, Vol. 17, No. 9, 01.04.2017, p. 959-985.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Multi-target directed indole based hybrid molecules in cancer therapy

T2 - An up-to-date evidence-based review

AU - Sunil, Dhanya

AU - Kamath, Pooja R.

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Cancer is a multifactorial disease and most of its types still remain incurable, in spite of enormous efforts to explicate various tumor pathophysiology. The anti-cancer drug discovery paradigm “one-compound-one-target” has failed and subsequently shifted to two-drug cocktail and recently the “multi-target approach” in order to design and develop agents able to act simultaneously on multiple intracellular constituents and signaling pathways. Novel hybrid compounds are now designed by incorporating two covalently linked independently acting pharmacores, each efficient at combating cancer. They can deliver synergistic effects from the dual action of both independently acting moieties by interacting with multiple targets. These composite molecules are also less prone to drug resistance, leading to an improved pharmacological potency than each individual moiety. As indole nucleus is a central component of many natural and synthetic molecules with extensive biological activity, this review incorporates a variety of such hybrid compounds with indole moiety as one of the active units, where better therapeutic effect has been successfully achieved, by either simultaneous or sequential action of individual functional pharmacore. The current limitations and challenges encountered in the development of these hybrid agents are also discussed.

AB - Cancer is a multifactorial disease and most of its types still remain incurable, in spite of enormous efforts to explicate various tumor pathophysiology. The anti-cancer drug discovery paradigm “one-compound-one-target” has failed and subsequently shifted to two-drug cocktail and recently the “multi-target approach” in order to design and develop agents able to act simultaneously on multiple intracellular constituents and signaling pathways. Novel hybrid compounds are now designed by incorporating two covalently linked independently acting pharmacores, each efficient at combating cancer. They can deliver synergistic effects from the dual action of both independently acting moieties by interacting with multiple targets. These composite molecules are also less prone to drug resistance, leading to an improved pharmacological potency than each individual moiety. As indole nucleus is a central component of many natural and synthetic molecules with extensive biological activity, this review incorporates a variety of such hybrid compounds with indole moiety as one of the active units, where better therapeutic effect has been successfully achieved, by either simultaneous or sequential action of individual functional pharmacore. The current limitations and challenges encountered in the development of these hybrid agents are also discussed.

UR - http://www.scopus.com/inward/record.url?scp=85013763995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013763995&partnerID=8YFLogxK

U2 - 10.2174/1568026616666160927150839

DO - 10.2174/1568026616666160927150839

M3 - Review article

C2 - 27697057

AN - SCOPUS:85013763995

VL - 17

SP - 959

EP - 985

JO - Current Topics in Medicinal Chemistry

JF - Current Topics in Medicinal Chemistry

SN - 1568-0266

IS - 9

ER -